ArticleJournal of thoracic disease2026

First-line therapies with maintenance regimens for driver gene-negative advanced non-small cell lung cancer (NSCLC): a systematic review and network meta-analysis of 61 randomized trials.

Ye Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.